NCT07495046

Brief Summary

Low Excision and High Suspension Hemorrhoidectomy versus Conventional Milligan-Morgan Hemorrhoidectomy for Mixed Hemorrhoids

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Completed
Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

March 17, 2026

Last Update Submit

March 21, 2026

Conditions

Keywords

Mixed Hemorrhoidslow excision and high suspension hemorrhoidectomyMilligan-Morgan hemorrhoidectomy;

Outcome Measures

Primary Outcomes (2)

  • Clinical effective rate at 12 weeks postoperatively

    Cured (complete resolution of symptoms and hemorrhoid prolapse) + improved (obvious relief of clinical symptoms) / total number of patients; an effective rate ≥90% was defined as clinically effective.

    12 weeks postoperatively

  • Hemorrhoid recurrence rate at 12 months postoperatively

    Recurrence was defined as the reappearance of hemorrhoid prolapse or rectal bleeding requiring clinical reintervention during the follow-up period.

    12 months postoperatively

Study Arms (2)

Study Group

EXPERIMENTAL

Low Excision and High Suspension Hemorrhoidectomy

Procedure: Low Excision and High Suspension Hemorrhoidectomy

control Group

ACTIVE COMPARATOR

Conventional Milligan-Morgan Hemorrhoidectomy

Procedure: Conventional Milligan-Morgan Hemorrhoidectomy

Interventions

Low Excision and High Suspension Hemorrhoidectomy

Study Group

Conventional Milligan-Morgan Hemorrhoidectomy

control Group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with Goligher grade III-IV mixed hemorrhoids via anorectal examination;
  • Failed conservative treatment for at least 3 months;
  • Voluntarily participated in the study and agreed to complete the 12-month follow-up.

You may not qualify if:

  • History of previous anorectal surgery;
  • Severe coagulation dysfunction, cardiopulmonary insufficiency, hepatic/renal failure, or mental disorders;
  • Pregnancy or lactation;
  • Inability to cooperate with postoperative follow-up and evaluation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients were randomly assigned 1:1 to the LEHS group or MM group using a computer-generated random number table with block randomization (block size=4). Allocation concealment was achieved using sealed, opaque envelopes, which were opened only on the day of surgery. Outcome assessors (responsible for pain scoring, complication recording, and manometry testing) and statistical analysts were blinded to group assignments to minimize bias.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician, Principal Investigator

Study Record Dates

First Submitted

March 17, 2026

First Posted

March 27, 2026

Study Start

April 1, 2026

Primary Completion

June 1, 2026

Study Completion

July 1, 2026

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share